Author

L. Campion

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Approach:statistical model· 3 Research Focus:chromatin & epigenetic regulation· 2 Assay:DNA methylation· 2 Assay:ATAC-seq· 1 Assay:bulk RNA-seq· 1 Research Focus:gene regulatory network inference· 1 Research Focus:protein folding & dynamics· 1

Frequent Co-Authors

C. Guerin-Charbonnel· 3 shared F. Magrangeas· 3 shared P. Moreau· 3 shared S. Minvielle· 3 shared C. Herrmann· 2 shared E. Douillard· 2 shared H. Avet-Loiseau· 2 shared J. Derrien· 2 shared

Activity by Year

2019-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

C. Guerin-Charbonnel

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Chromatin accessibility combined with enhancer clusters activation mediates heterogeneous response to dexamethasone in myeloma cells

V. GABORIT, J. CRUARD, C. Guerin-Charbonnel, J. Derrien, J.-B. Alberge, E. Douillard, N. Roi, M. Devic, L. Campion, F. Westermann, P. Moreau, C. Herrmann, J. Bourdon, F. Magrangeas, S. Minvielle

The paper investigates how chromatin accessibility and enhancer clusters mediate heterogeneous responses to dexamethasone in myeloma cells, showing epigenomic changes linked to transcriptional heterogeneity.

bioRxiv · Sep 6, 2021 · PreprintCancer Biology

The DNA methylation landscape of multiple myeloma shows extensive inter- and intrapatient heterogeneity that fuels transcriptomic variability

J. Derrien, C. Guerin-Charbonnel, V. Gaborit, L. Campion, M. Devic, E. Douillard, N. Roi, H. Avet-Loiseau, O. Decaux, T. Facon, J.-P. Mallm, R. Eils, N. C. Munshi, P. Moreau, C. Herrmann, , S. Minvielle

This study examines DNA methylation heterogeneity in multiple myeloma, linking it to transcriptomic variability and poor patient outcomes through epigenetic and structural changes.

bioRxiv · Oct 1, 2020 · PreprintCancer Biology

DNA hydroxymethylation reveals transcription regulation networks and prognostic signatures in multiple myeloma

J.-B. Alberge, F. Magrangeas, M. Wagner, S. Denie, C. Guerin-Charbonnel, L. Campion, M. Attal, H. Avet-Loiseau, T. Carell, P. Moreau, S. Minvielle, A. A. Serandour

This study analyzes DNA hydroxymethylation in multiple myeloma to identify regulation networks and prognostic signatures associated with disease progression and survival.

bioRxiv · Oct 16, 2019Cancer Biology